EIB lends up to €110 million to Dräger for medical technology development

EPA-EFE//ULRICH PERREY

EIB lends up to €110 million to Dräger for medical technology development


Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+

Medical technology giant Dräger will receive up to €110 million to fund R&D projects targeting life-saving systems and ventilators.

The EU bank’s loan is backed by a guarantee from the European Fund for Strategic Investments (EFSI), the heart of the Investment Plan for Europe known as “the Juncker Plan” under which the EIB and the European Commission are working together as strategic partners and the EIB’s financing operations are actively propping up the competitiveness of the European economy.

“The products and systems that Dräger is developing are making our lives safer and healthier. From intensive care monitoring systems to premature infant respirators, this company is creating groundbreaking innovations. With €110 million in financing from the EU’s investment bank, and supported by the Investment Plan for Europe, Dräger can continue to push boundaries in medical technology.”, said Jyrki Katainen, European Commission Vice-President for Jobs, Growth, Investment and Competitiveness.

Dräger will be using the new internationally secure IEEE 11073 standard for medical device communication, which the company itself has helped to develop.

“We are working toward connecting medical devices for a system to improve clinical decisions. This development will lead to assisted therapy and ultimately hospital automation,” said Stefan Dräger, Chairman of the Executive Board of Drägerwerk Verwaltungs AG.

Share on Facebook
Share on Twitter
Share on Google+
Share on LinkedIn
+